help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Erickson, D.
Right arrow Articles by Young, W. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Erickson, D.
Right arrow Articles by Young, W. F., Jr.
The Journal of Clinical Endocrinology & Metabolism Vol. 86, No. 11 5210-5216
Copyright © 2001 by The Endocrine Society


Endocrine Care

Benign Paragangliomas: Clinical Presentation and Treatment Outcomes in 236 Patients

Dana Erickson, Yogish C. Kudva, Michael J. Ebersold, Geoffrey B. Thompson, Clive S. Grant, Jon A. van Heerden and William F. Young, Jr.

Division of Endocrinology, Metabolism, Nutrition, and Internal Medicine (D.E., Y.C.K., W.F.Y.), Department of Neurosurgery (M.J.E.), and Department of Surgery (G.B.T., C.S.G., J.A.v.H.), Mayo Clinic, and Mayo Foundation, Rochester, Minnesota 55905

Address all correspondence and requests for reprints to: William F. Young, Jr., M.D., Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905. E-mail: Young.William{at}mayo.edu

Abstract

Paragangliomas are rare tumors that arise from extraadrenal chromaffin cells. We examined the clinical characteristics, location, treatment, and outcome of 236 patients (141 females, 60%) with 297 benign paragangliomas evaluated at the Mayo Clinic during 1978–1998. The mean age (±SD) at diagnosis was 47 ± 16 yr. Of the 297 paragangliomas, 205 were in the head and neck region, and 92 were below the neck. Paragangliomas were discovered and diagnosed incidentally on imaging studies in 9% of patients. Biochemical screening was performed in 128 patients; 40 patients (17% of the total and 31% of those screened) had hyperfunctional tumors. Of the 40 patients with tumoral catecholamine excess, 38 had documented hypertension. In patients identified with catecholamine-secreting paragangliomas, the sensitivities achieved by measurements in the 24-h urine collection were 74% for total metanephrines, 84% for norepinephrine, 18% for dopamine, and 14% for epinephrine. Multiple imaging modalities were used for tumor localization. The false negative rates were 0% for magnetic resonance imaging, 5.8% for computed tomography, 3.4% for angiography, 10.7% for ultrasonography, and 39% for radioactive iodine-labeled metaiodobenzylguanidine scintigraphy. Of 192 patients (81.4%) with follow-up data (mean, 43.9 months; range, 0.5–240), operative cure was achieved in 133 (69%). Of the 59 patients without cure, 23 had persistent disease, 5 had recurrent disease, 16 had multiple persistent synchronous tumors, and 15 subsequently developed metachronous tumors. In conclusion, most paragangliomas are nonhypersecretory and located in the head and neck region. Magnetic resonance imaging was associated with the lowest false negative rate, and metaiodobenzylguanidine was the least sensitive imaging study. A significant proportion of patients (31%) has persistent or recurrent disease, and long-term follow-up is important.




This article has been cited by other articles:


Home page
Endocr Relat CancerHome page
A. Karagiannis, D. P Mikhailidis, V. G Athyros, and F. Harsoulis
Pheochromocytoma: an update on genetics and management
Endocr. Relat. Cancer, December 1, 2007; 14(4): 935 - 956.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
E. ZAPANTI and I. ILIAS
Pheochromocytoma: Physiopathologic Implications and Diagnostic Evaluation
Ann. N.Y. Acad. Sci., November 1, 2006; 1088(1): 346 - 360.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
W. F YOUNG JR
Paragangliomas: clinical overview.
Ann. N.Y. Acad. Sci., August 1, 2006; 1073: 21 - 29.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
H. AHLMAN
Malignant pheochromocytoma: state of the field with future projections.
Ann. N.Y. Acad. Sci., August 1, 2006; 1073: 449 - 464.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
K. Y. Lee, Y.-W. Oh, H. J. Noh, Y. J. Lee, H.-S. Yong, E.-Y. Kang, K. A. Kim, and N. J. Lee
Extraadrenal paragangliomas of the body: imaging features.
Am. J. Roentgenol., August 1, 2006; 187(2): 492 - 504.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
W. F. Young Jr and A. L. Abboud
Paraganglioma--all in the family.
J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 790 - 792.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. Eisenhofer, D. S. Goldstein, P. Sullivan, G. Csako, F. M. Brouwers, E. W. Lai, K. T. Adams, and K. Pacak
Biochemical and Clinical Manifestations of Dopamine-Producing Paragangliomas: Utility of Plasma Methoxytyramine
J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2068 - 2075.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
D. G. Abud, C. Mounayer, G. Benndorf, M. Piotin, L. Spelle, and J. Moret
Intratumoral Injection of Cyanoacrylate Glue in Head and Neck Paragangliomas
AJNR Am. J. Neuroradiol., October 1, 2004; 25(9): 1457 - 1462.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
G. A. Kaltsas, G. M. Besser, and A. B. Grossman
The Diagnosis and Medical Management of Advanced Neuroendocrine Tumors
Endocr. Rev., June 1, 2004; 25(3): 458 - 511.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
V. D. Garovic, M. C. Hogan, S. K. R. Kanakiriya, C. S. Grant, and W. F. Young Jr
Labile hypertension, increased metanephrines and imaging misadventures
Nephrol. Dial. Transplant., April 1, 2004; 19(4): 1004 - 1006.
[Full Text] [PDF]


Home page
RadioGraphicsHome page
D. P. Saurborn, J. B. Kruskal, I. E. Stillman, and S. Parangi
Best Cases from the AFIP: Paraganglioma of the Organs of Zuckerkandl
RadioGraphics, September 1, 2003; 23(5): 1279 - 1286.
[Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
C. A. KOCH, A. O. VORTMEYER, Z. ZHUANG, F. M. BROUWERS, and K. PACAK
New Insights into the Genetics of Familial Chromaffin Cell Tumors
Ann. N.Y. Acad. Sci., September 1, 2002; 970(1): 11 - 28.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. L. Young, B. E. Baysal, A. Deb, and W. F. Young Jr.
Familial Malignant Catecholamine-Secreting Paraganglioma with Prolonged Survival Associated with Mutation in the Succinate Dehydrogenase B Gene
J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4101 - 4105.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
B E Baysal
Hereditary paraganglioma targets diverse paraganglia
J. Med. Genet., September 1, 2002; 39(9): 617 - 622.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
R. G. Dluhy
Pheochromocytoma -- Death of an Axiom
N. Engl. J. Med., May 9, 2002; 346(19): 1486 - 1488.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2001 by The Endocrine Society